barriers to the waitlist and transplantation such as lower socioeconomic status, long distance to a transplant center, lack of access to a nephrologist, or immunologic barriers. [16] [17] [18] [19] [20] This was particularly a concern for African American registrants and registrants with highly sensitized immune systems, measured by calculated panel reactive antibody (cPRA), who experienced increased difficulty in finding an organ match and increased risk of graft rejection. 16, 21, 22 Given these inefficiencies, the KAS was developed with the intention to increase DDKT rates for highly sensitized registrants and racial minorities who historically have disproportionately lower DDKT rates than their counterparts. 23 Due to this shifting of priorities under KAS, there are concerns that DDKT rates for pediatric registrants could be reduced. Since KAS implementation, two early studies of the entire kidney waitlist demonstrated increased DDKT rates for highly sensitized registrants and those with extended time on dialysis. 24, 25 Moreover, both studies provided evidence that pediatric DDKT rates have remained statistically consistent with DDKT rates under the previous allocation system. While these studies contributed important information about the impact of KAS, they were limited in their scope, only examining transplant rates within the first year post-KAS. Thus, to further understand the landscape of pediatric DDKT pre-and post-KAS, we chose to assess overall DDKT trends in addition to individual likelihood of DDKT given greater post-KAS follow-up among pediatric registrants. We hypothesized the pediatric DDKT rate would initially decrease with KAS implementation but would subsequently recover to pre-KAS rates with greater time post-KAS as the bolus effect dissipated. Additionally, we hypothesized that groups targeted by KAS, specifically highly sensitized and minority pediatric registrants, would experience an increase in DDKT rate.
| METHODS

| Data source
This study used data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes information on all donors, wait-listed candidates, and transplant recipients in the US, submitted by the members of the Organ Procurement and Transplantation Network (OPTN), and has been described elsewhere. 26 The Health Resources and Services Administration of the US Department of Health and Human Services provides oversight to the activities of the OPTN and SRTR contractors.
| Study population
All pediatric (<18 years of age), kidney-only waitlist registrations be- 
| Exploratory data analyses
Registrants on the waitlist as of January 1, 2013 were categorized as Era 1 while new additions were categorized according to their listing date. Registrant characteristics were compared across allocation era.
Dialysis time was analyzed using Kruskal-Wallis tests, and categorical variables were explored using chi-square tests of independence.
| Outcome ascertainment
The outcome of pediatric DDKT was considered in two distinct analy- 
| Statistical analyses
| Interrupted time series analyses
The uniform implementation of KAS allows for analysis using an ITS design, a type of quasi-experimental study design, to assess the significance of changes in level and slope of DDKT among pediatric registrants before and after the introduction of each allocation era. 27 We examined the monthly DDKT rate per 100 registrations on the waitlist in that month in a segmented regression model containing a continuous variable for baseline trend, dummy variables for allocation Eras 2 and 3, and continuous time trends after the change in allocation eras.
Given concern that the use of registrations in the denominator might bias our results, we replicated our analyses using the monthly DDKT rate per 100 active listings on the waitlist in that month.
| Predicted values
The beta estimates obtained from the segmented regression were
used to obtain what the hypothetical value (pre-KAS projected value)
would be in the same time period, had no change in allocation system occurred. In this counterfactual situation, the value of "era2" and "era3" remained at 0, and the "post_time" and "post_time2" variables were not included. The beta estimates were also used to obtain the predicted values in Eras 2 and 3 which were plotted for graphical comparison of estimated DDKT rates. The percent change in DDKT rate between the pre-KAS projected rate and the predicted rates in Eras 2 and 3 was calculated at time points of interest.
| Time-to-event analyses
To understand individual likelihood of DDKT, Cox proportional hazards models were built using the counting process data structure to accommodate left truncation, allowing for modeling of allocation eras as time-dependent variables. 28 Through this data structure, registrants on the waitlist in Era 1 contributed time at-risk to the Era 1 group until implementation in Era 2, after which they contributed time-at-risk to Era 2. Covariates were initially informed by SRTR's risk-adjustment models with the final set of covariates selected using univariable models with significance set at α = 0.10. The final models included age at listing, race, sex, cPRA, blood type, previous kidney transplantation, pre-listing dialysis duration, inactive status on the waitlist (during which time they are precluded from DDKT), and ESRD etiology, categorized as congenital abnormalities of the urinary tract and kidney (CAKUT), genetic, glomerular/autoimmune, and other/unknown. Given the small number of observations with missing data (n = 17), missing observations were coded as a "Missing/Unknown" level to allow for incorporation in adjusted analyses and to assess for potential bias attributable to missingness. Lastly, to assess differential associations between registrant characteristics across allocation eras, we built a series of models, each of which contained a first-degree interaction term between a registrant characteristic and allocation era. We used two-sided tests for interpretation of statistical significance at α = 0.05 and performed all analyses using SAS version 9.4 (Cary, NC).
| Sensitivity analyses
Given concerns about systematic differences between prevalent and incident registrants, we conducted a sensitivity analysis in which we limited our cohort to only incident listings. Inferences were consistent with those obtained using the prevalent cohort. Initial analyses included all registrants on the waitlist, including those who were always inactive. However, as those who were always inactive were never truly able to receive a DDKT, we conducted a sensitivity analysis in which we excluded those registrants from our cohort and censored registrants during time inactive on the waitlist. Inferences were confirmed.
Similarly to those who are always inactive, the youngest registrants (aged <2 years) might also be ineligible for receiving a DDKT and thus, we incorporated a separate age category for those registrants in an additional sensitivity analysis and inferences were confirmed. While censoring, we replicated all analyses using Fine and Gray regression to account for these competing risks and our inferences were confirmed.
All sensitivity analyses are presented as supplemental tables.
| RESULTS
| Listing population
There were 5095 pediatric registrations during the study period: 2535 registrants on the waitlist in Era 1; 517 additions in Era 2; and 2043 
| Overall pediatric DDKT rate
There were 1979 pediatric DDKT during the study period. Seven hundred and 78 DDKT occurred in Era 1; 243 in Era 2; and 958 in Era 3. Interrupted time series analysis revealed no statistically significant changes in overall pediatric DDKT rate across allocation era. In
December 2014, the month KAS went into effect, the DDKT rate was 3.52 per 100 registrations. The rate of DDKT in Era 1 was estimated to have a slope of β = 0.01 (95% CI: −0.05 to 0.07, P = .74) while the Era 3 slope was estimated as β = 0.30 (95% CI: −0.09 to 0.69, P = .12).
The estimated DDKT rate projected for December 2016 had KAS not been implemented was 3.97 per 100 registrations compared to the actual rate of 3.68 per 100 registrations, a 7.9% decrease that was not statistically significant (Tables 2, S16 , and Figure 1A ).
Similarly, when using Cox proportional hazards, there was no statistically significant association between allocation era and DDKT after adjustment for listing characteristics as compared to Era 1 (Era 3: aHR: 1.07, 95% CI: 0.97-1.18, P = .17, Table S1 , supplemental material). Older age at listing, blood type AB, increasing dialysis time, and active status on the waitlist were associated with greater likelihood of DDKT; whereas high sensitization, blood type B, and history of previous kidney transplant were associated with lower likelihood of DDKT (Table S1 , supplemental material). Similar conclusions were obtained in our sensitivity analyses (Tables S4, S8 , S12, S17, S21, and S25, supplemental material).
| Subgroup pediatric DDKT rates
Among AA pediatric registrants, the DDKT rate in December 2014 was 0.97 per 100 registrations, with a decreasing slope in Era 1 (β = −0.02, 95% CI:−0.03 to −0.001, P = .03). After KAS, the slope for AAs reversed and was increasing in Era 3 (slope: 0.25, 95% CI: 0.09 to 0.41, P = .002) ( Table 2 and Figure 1B ). The estimated DDKT rate for pediatric AAs projected in December 2016 had KAS not been implemented was 0.45 per 100 registrations compared to the actual rate of 0.80 per 100 registrations, a 45.6% increase. When examining the monthly DDKT rate per 100 active listings, similar trends were noted (Table S15 , supplemental material). However, a similar change was not observed when comparing the individual likelihood of DDKT for AAs in Era 3 to Era 1 (aHR: 1.00, 95% CI: 0.82-1.22, P = .98) (Table S2 , supplemental material). This finding was consistent in our sensitivity analyses (Tables S6, S10 , S13, S19, S23, and S27, supplemental material).
For registrants aged 0-6, the DDKT rate in December 2014 was 0.80, with a slope of β = 0.001 in Era 1 (95%CI: −0.02 to 0.02, P = .95)
while the slope in Era 3 was estimated as β = 0.12 (95%CI: −0.02 to 0.25, P = .08) ( Table 2 and Figure 1C ). After accounting for the washout period, (Table S3 , supplemental material).
After restricting to active registrants and adding an age category for registrants aged <2 at time of listing, the negative association between Era 3 and DDKT among young registrants, particularly those aged < 2, persisted (Tables S7, S11 , S14, S20, S24, S28, supplemental material.)
Lastly, while the ITS analysis did not reveal any significant changes in DDKT, a statistically significant interaction between high sensitization and era was present in the time-to-event analyses, such that while highly sensitized pediatric registrants were consistently less likely to be transplanted than their less sensitized counterparts, this disparity was attenuated in Era 3 (Era 1 aHR: 0.04, 95%CI: 0.01-0.14, P < .001; Era 3 aHR: 0.33, 95% CI: 0.21-0.53, P < .001) ( Table 3) . This attenuation was consistently demonstrated in all sensitivity analyses (Tables S5, S9 , S13, S18, S22, S26, supplemental material).
| DISCUSSION
In this study of pediatric DDKT transplant before and after KAS implementation, we demonstrate that the overall DDKT rate among pediatric registrants has remained stable. KAS was designed to improve DDKT rates for African Americans and highly sensitized candidates in the adult population, and our data suggest that has also occurred in the pediatric population. Additionally, we found an age effect, with children between the ages of 0 and 6 years negatively impacted by the implementation of KAS, such that the predicted DDKT rate in December 2016 was 15% lower than would have been expected had KAS not been implemented.
The stability observed over this period should alleviate the expressed concerns that KAS would reduce DDKT rates among pediatric registrants. 23 Our results extend earlier work showing stable DDKT rates early after KAS implementation among the pediatric population. 24, 25 Importantly, we demonstrate DDKT increased for one of the subgroups targeted by KAS: pediatric registrants who were highly sen- and Hispanic registrants when their study follow-up period was partitioned into three eras. 30 Our data suggest that pediatric African
American registrants also experienced a significant increase in DDKT rate post-KAS implementation, but further study with prolonged post-KAS follow-up is needed to assess whether this increase in DDKT rate for African American pediatric registrants will be maintained or if it is simply an additional component of the bolus effect.
Not all groups benefited from the allocation change; specifically, children between the ages of 0 and 6 years experienced a decrease in DDKT rate of 14.9% in December 2016. The SRTR annual data report from 2015 indicates that candidates under the age of 6 experienced the lowest unadjusted transplant rate of all pediatric age groups as opposed to previous years in which their transplant rate was comparable or higher than other pediatric age groups. 31 Perhaps not surprisingly, infants and small children might have lower DDKT rates as compared to their older counterparts, due to perceived increased risk of graft loss and the technical difficulty of the surgery. 32, 33 Our data demonstrate that the age disparity post-KAS has continued to widen. One possible explanation for this lower rate is increased organ discard. Smith et al noted that discard of small (≤20 kg) pediatric donor kidneys has increased post-KAS, as height and age confer a higher KDPI to young, small donors. 34 Given the high KDPIs, the authors posit these small donor kidneys, which might provide a survival benefit to young pediatric candidates, are being discarded. Despite reluctance to use these grafts in small recipients due to the increased risk of surgical complications, discard represents a suboptimal utilization of organs. 35, 36 Beyond discard, Nazarian et al noted a significant decrease in the proportion of pediatric donors transplanted into pediatric recipients post-KAS as compared to pre-KAS, suggesting that the donor pool available to children has been restricted post-KAS to exclude many pediatric donors due to KDPI. 37 Moreover, allocation of pediatric donors based upon KDPI is likely flawed as KDPI has been shown to be a poor predictor of graft outcomes among pediatric donors. 37, 38 Considering the high mortality rates on dialysis and the deleterious effect of prolonged dialysis duration on growth and development among these young pediatric registrants, further monitoring of DDKT rates in this population is warranted to guarantee DDKT rates are not further eroded. 1, 7, 9, 39 The inferences derived from this study are limited by the availability and quality of the information within the national transplant registry. As with any observational study, there is the potential for confounding due to unmeasured or unknown factors. However, we explored the data for potential confounding and have adjusted accordingly. Additionally, while ITS provides strong evidence of the association between allocation era and pediatric DDKT rate, we lack an appropriate control group which was not impacted by these trends.
Thus, we are unable to isolate the effect of secular trends, such as changes in listing patterns and are unable to assert that there were no simultaneous changes which might have influenced pediatric DDKT rate, prohibiting causal interpretation of our findings. Despite these Bold indicates significance at P < .05.
T A B L E 3 Likelihood of deceased donor kidney transplant among pediatric registrants acknowledged limitations, the data generated from this cohort provides important and new information about DDKT under the new allocation system in the pediatric population.
To date, this is the first national study to explore DDKT rate among pediatric registrants under the new allocation system. Our findings demonstrate that the overall pediatric DDKT rate has remained consistent across allocation eras, but also revealed that pediatric registrants between 0 and 6 years of age have experienced a significant decline in DDKT. In contrast, those who are highly sensitized have experienced an increase in DDKT under KAS. Given the deleterious effect of dialysis in pediatric registrants, particularly among the youngest registrants, further study to monitor transplant rates among very young registrants and transplant outcomes is warranted. 
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